Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Priority Review
.
Show all posts
Showing posts with label
Priority Review
.
Show all posts
Wednesday, August 7, 2024
Lykos Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD
›
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) ("Lykos"), a company dedicated to transforming mental healthcare, an...
Wednesday, May 8, 2019
U.S. FDA Grants Priority Review for Fedratinib New Drug Application in Myelofibrosis
›
Celgene Corporation (NASDAQ:CELG) announced the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application ...
›
Home
View web version
